(Press-News.org) Scientists, for the first time, have identified a mechanism in the muscle cells of the uterus that could point to how contractions in childbirth grow stronger.
It is understood that the hormone oxytocin plays a significant role in stimulating contractions during labour, which helps to move a baby down the birth canal. It is not known, however, how these contractions increase and sustain their strength during hours of labour.
A team at Liverpool investigated how uterine contractions grow stronger when the human body's 'biological rules' dictates that contractions should grow weaker as the tightening muscle squeezes the blood vessels, reducing oxygen and blood flow.
Professor Susan Wray, from the University's Institute of Translational Medicine, explains: "Laboratory tests have shown us that even when the hormone, oxytocin, is interrupted, surprisingly the muscle carries on contracting, and can grow stronger.
"This tells us that oxytocin's role, although significant, is not the only thing contributing to how this vital muscle contracts during labour. These findings prompted us to ask the question - how does this powerful muscle carry on working against the odds?"
The team looked for clues in studies on heart muscle, where a phenomenon called hypoxic preconditioning can elicit cellular changes that can protect it from more serious drops in oxygen, which can be life-saving.
The team, which also including PhD student, Mohammed Alotaibi and post-doctoral researcher Sarah Arrowsmith, found that the uterus reacts to the repetitive lack of blood supply and oxygen, by triggering another, previously unknown, process in the muscle cells that the Liverpool researchers have called hypoxia-induced force increase (HIFI).
In the laboratory they found that routine contractions in sample uterine tissue, when experimentally subjected to repeated, transient dips in oxygen (hypoxia), responded by gradually increasing in strength. Once the HIFI mechanism had been triggered it was sustained for many hours, just as occurs in labour.
Professor Wray added: "This is an exciting discovery, not only for increasing our general understanding of how biological systems can respond to the stress of low oxygen but for opening up new research pathways into difficult labours.
"We now believe that this uterine trigger could be key to resolving issues of prolonged labour, as well as the increasing number of births that result in emergency caesarean."
INFORMATION:
The research is funded by a PhD Fellowship from KSA and published in the journal Proceedings of the National Academy of Sciences (PNAS).
SEATTLE, WA, AUGUST 12, 2015 - If a defensive coordinator of a National Football League (NFL) team could predict with high accuracy whether their team's opponent will call a pass or run play during a game, he would become a rock star in the league and soon be a head coach candidate.
William Burton, an industrial engineering student who is minoring in statistics at North Carolina State University (NCSU), and collaborator Michael Dickey, a statistics major who graduated from NCSU in May, have built a statistical model that predicts the play-calling tendency of NFL teams ...
SEATTLE, WA, AUGUST 12, 2015 - The growing popularity and use of social media around the world is presenting new opportunities for statisticians to glean insightful information from the infinite stream of posts, tweets and other online communications that will help improve public safety.
Two such examples--one that enhances systems to track foodborne illness outbreaks and another designed to improve disaster-response activities--were presented this week at the 2015 Joint Statistical Meetings (JSM 2015) in Seattle.
Tracking Foodborne Illness Outbreaks:
In a presentation ...
SEATTLE, WA, AUGUST 12, 2015 - Panelists talked about various aspects of value-added models, commonly referred to as VAMs, while the discussant posed a new question about the use of evaluation models during a panel discussion on the hot-button topic today at the 2015 Joint Statistical Meetings (JSM 2015) in Seattle.
The panel discussion, titled "Value-Added Models: A Primer and Discussion," featured four experts in the areas of statistics, education research and VAMs. They are:
Jennifer E. Broatch, assistant professor of statistics at Arizona State University
Jennifer ...
New UBC research into brain cancer suggests treatments should target the cells around a tumor to stop it from spreading.
UBC research team Christian Naus, Wun Chey Sin and John Bechberger study glioma, the most aggressive form of adult brain cancer. Glioma has a low five-year survival rate of 30 per cent because it is difficult to completely remove cancer cells without compromising brain functions and chemotherapy and radiotherapy do not prevent the regrowth of remaining cancer cells.
With this new research, the team reveals an alternative route to rein in the glioma ...
Researchers at New Zealand's University of Otago have discovered why heart disease is the number-one killer of people with diabetes, a breakthrough finding opening the way for new treatments to combat the disease in diabetic patients by targeting a key protein called Beclin-1.
Diabetes affects more than 365 million people worldwide with rates expected to double by 2030. Recent studies show that at least 60% of people with the disease die because of cardiovascular complications.
Why diabetes takes such a toll on heart health has long remained a mystery. Now, in a new ...
The U.S. Food and Drug Administration recently approved the first new drug to fight tuberculosis (TB) in more than 40 years, but treatment still takes six months, 200 pills and leaves 40 percent of patients uncured. Thus, new targets are needed. Today in ACS Central Science, researchers report they have identified one such target -- a gene that allows the disease to camp out in human immune cells, and is thus essential for the organism's proliferation.
TB kills about 1.3 million people around the world every year. The microorganism that causes the disease, Mycobacterium ...
IVF success rates for women aged 43 and above could improve by retrieving eggs from their ovaries at an earlier stage of fertility treatment, according to a new study published today in the Journal of Endocrinology.
US-based researchers found that the function of cells which nurse and support the development of eggs declines rapidly after 43, causing the egg to be bombarded by hormones that are normally only released after ovulation. Retrieving eggs from smaller follicles at an earlier stage in the IVF process was found to minimise this risk, resulting in a higher quality ...
August 12, 2015--(BRONX, NY)--Using real-time, high-resolution imaging, scientists have identified how a "doorway" in the blood vessel wall allows cancer cells to spread from breast tumors to other parts of the body. The findings lend support to emerging tests that better predict whether breast cancer will spread, which could spare women from invasive and unnecessary treatments, and could lead to new anti-cancer therapies. The research, conducted by investigators at the NCI-designated Albert Einstein Cancer Center (AECC) and Montefiore Einstein Center for Cancer Care, utilized ...
CLEVELAND, Ohio (August 12, 2015)--Local vaginal estrogen (VE) appears to have escaped the shroud of doubt cast upon hormone therapy as a result of the Women's Health Initiative Study (WHI) by providing numerous medical benefits without systemic effects. That's according to a new study reported online today in Menopause, the journal of The North American Menopause Society (NAMS).
The study demonstrated that postmenopausal women who suffer from painful intercourse and vaginal dryness are more likely to use VE, regardless of whether they use any other type of hormone therapy. ...
Cost of radiation therapy among Medicare patients varied most widely because of factors unrelated to a patient or that person's cancer, report University of California, San Diego School of Medicine researchers in the Journal of Oncology Practice.
Year of diagnosis, location of treatment, clinic type and individual radiation provider accounted for 44 to 61 percent of the variation in cost for patients with breast, lung and prostate cancer therapies, according to the study published August 11 online. Factors associated with the patient or patient's tumor accounted for less ...
